Ha habido 50 transacciones internas recientes registradas para Immunovant, Inc. (IMVT), incluyendo 16 compras y 31 ventas. El total de compras internas fue valorado en $369.18M y el total de ventas internas en $10.29M.
Internos destacados con actividad reciente incluyen Venker Eric, Van Tuyl Christopher, Gloria Melanie. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — IMVT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-02 |
Venker Eric |
Chief Executive Officer |
Venta Informativa |
1,409 |
$24.60 |
$34.66K |
19,561 |
| 2026-04-01 |
Venker Eric |
Chief Executive Officer |
Devolución de Acciones |
334,960 |
$25.10 |
$8.41M |
33,790 |
| 2026-03-18 |
Van Tuyl Christopher |
Chief Legal Officer |
Venta Informativa |
2,877 |
$24.97 |
$71.84K |
147,053 |
| 2026-02-25 |
Gloria Melanie |
Chief Operating Officer |
Venta Informativa |
942 |
$28.90 |
$27.22K |
170,273 |
| 2026-01-21 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
1,977 |
$26.03 |
$51.46K |
197,634 |
| 2026-01-07 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
55 |
$26.92 |
$1.48K |
199,611 |
| 2025-12-18 |
Van Tuyl Christopher |
Chief Legal Officer |
Venta Informativa |
2,284 |
$27.38 |
$62.54K |
149,930 |
| 2025-12-12 |
Roivant Sciences Ltd. |
10 Percent Owner |
Compra Informativa |
16,666,666 |
$21.00 |
$350M |
113,317,007 |
| 2025-12-01 |
Fromkin Andrew J. |
Director |
Venta Informativa |
2,898 |
$23.95 |
$69.41K |
85,852 |
| 2025-12-01 |
Hughes Douglas J. |
Director |
Venta Informativa |
1,909 |
$23.96 |
$45.74K |
120,773 |
| 2025-11-20 |
Gloria Melanie |
Chief Operating Officer |
Venta Informativa |
2,375 |
$23.97 |
$56.93K |
173,511 |
| 2025-10-22 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
2,520 |
$19.03 |
$47.96K |
200,814 |
| 2025-10-22 |
Geffner Michael |
Chief Medical Officer |
Venta Informativa |
2,595 |
$19.03 |
$49.38K |
217,958 |
| 2025-10-08 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
1,585 |
$16.30 |
$25.84K |
203,334 |
| 2025-10-08 |
Geffner Michael |
Chief Medical Officer |
Venta Informativa |
1,272 |
$16.30 |
$20.73K |
220,553 |
| 2025-07-28 |
Venker Eric |
Chief Executive Officer |
Concesión de RSU |
189,900 |
$16.76 |
$3.18M |
189,900 |
| 2025-07-23 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
2,805 |
$18.15 |
$50.91K |
204,919 |
| 2025-07-23 |
Geffner Michael |
Chief Medical Officer |
Venta Informativa |
2,385 |
$18.15 |
$43.29K |
221,825 |
| 2025-07-09 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
1,519 |
$17.24 |
$26.19K |
207,724 |
| 2025-07-09 |
Geffner Michael |
Chief Medical Officer |
Venta Informativa |
1,160 |
$17.24 |
$20K |
224,210 |
| 2025-05-01 |
Girao Tiago |
Chief Financial Officer |
Concesión de RSU |
208,388 |
- |
- |
208,388 |
| 2025-05-01 |
Bauer Jake |
Director |
Concesión de RSU |
25,016 |
- |
- |
25,016 |
| 2025-05-01 |
Susman Robert Graham |
Director |
Concesión de RSU |
25,016 |
- |
- |
25,016 |
| 2025-04-23 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
1,925 |
$14.79 |
$28.47K |
209,243 |
| 2025-04-23 |
Geffner Michael |
Chief Medical Officer |
Venta Informativa |
2,349 |
$14.79 |
$34.74K |
225,370 |
| 2025-04-21 |
Girao Tiago |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-04-18 |
Bauer Jake |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-04-18 |
Susman Robert Graham |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-04-16 |
Salzmann Peter |
Chief Executive Officer |
Venta Informativa |
8,321 |
$14.89 |
$123.9K |
1,178,191 |
| 2025-04-16 |
Barnett Eva Renee |
Chief Financial Officer |
Venta Informativa |
2,993 |
$14.89 |
$44.57K |
396,774 |
| 2025-04-09 |
Salzmann Peter |
Chief Executive Officer |
Venta Informativa |
28,094 |
$12.99 |
$364.94K |
1,186,512 |
| 2025-04-01 |
Migausky George V |
Director |
Concesión de RSU |
7,600 |
$15.20 |
$115.52K |
7,600 |
| 2025-04-01 |
Fromkin Andrew J. |
Director |
Concesión de RSU |
7,600 |
$15.20 |
$115.52K |
7,600 |
| 2025-04-01 |
Pande Atul |
Director |
Concesión de RSU |
7,600 |
$15.20 |
$115.52K |
7,600 |
| 2025-04-01 |
Torti Frank |
Director |
Concesión de RSU |
93,599 |
$15.20 |
$1.42M |
93,599 |
| 2025-04-01 |
Stout Jay S |
Chief Technology Officer |
Concesión de RSU |
107,297 |
$15.20 |
$1.63M |
107,297 |
| 2025-04-01 |
Hughes Douglas J. |
Director |
Concesión de RSU |
7,600 |
$15.20 |
$115.52K |
7,600 |
| 2025-04-01 |
Van Tuyl Christopher |
Chief Legal Officer |
Concesión de RSU |
71,531 |
$15.20 |
$1.09M |
71,531 |
| 2025-04-01 |
Salzmann Peter |
Chief Executive Officer |
Concesión de RSU |
374,395 |
$15.20 |
$5.69M |
374,395 |
| 2025-04-01 |
Barnett Eva Renee |
Chief Financial Officer |
Concesión de RSU |
125,180 |
$15.20 |
$1.9M |
125,180 |
| 2025-04-01 |
Gloria Melanie |
Chief Operating Officer |
Concesión de RSU |
107,297 |
$15.20 |
$1.63M |
107,297 |
| 2025-04-01 |
Geffner Michael |
Chief Medical Officer |
Concesión de RSU |
143,063 |
$15.20 |
$2.17M |
143,063 |
| 2025-03-07 |
Fromkin Andrew J. |
Director |
Venta Informativa |
1,384 |
$19.96 |
$27.62K |
91,913 |
| 2025-02-19 |
Salzmann Peter |
Chief Executive Officer |
Venta Informativa |
15,439 |
$20.86 |
$322.06K |
948,786 |
| 2025-02-19 |
Macias William L. |
Chief Medical Officer |
Venta Informativa |
2,055 |
$20.86 |
$42.87K |
357,353 |
| 2025-02-19 |
Barnett Eva Renee |
Chief Financial Officer |
Venta Informativa |
2,814 |
$20.86 |
$58.7K |
321,952 |
| 2025-01-22 |
Stout Jay S |
Chief Technology Officer |
Venta Informativa |
2,195 |
$23.59 |
$51.78K |
139,991 |
| 2025-01-22 |
Geffner Michael |
Chief Medical Officer |
Venta Informativa |
2,657 |
$23.59 |
$62.68K |
132,314 |
| 2025-01-15 |
Salzmann Peter |
Chief Executive Officer |
Venta Informativa |
415 |
$24.19 |
$10.04K |
964,225 |
| 2025-01-15 |
Macias William L. |
Chief Medical Officer |
Venta Informativa |
19 |
$24.19 |
$459.61 |
359,408 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
